PURE Bioscience To Present At Friedland Investment Events’ West Coast Biotech, Medical And Healthcare Luncheons; PURE Bioscience’s Silver Dihydrogen Citrate Sets New Standard For Antimicrobials

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (OTCBB:PURE), developer, manufacturer and marketer of technology-based bioscience products providing non-toxic antimicrobial solutions, announced today that it will present at Friedland Investment Events’ Biotech, Medical and Healthcare Luncheons on September 27th in Irvine and 28th in Los Angeles.

MORE ON THIS TOPIC